Cancer diagnosis and prognosis decoded by blood-based circulating micro RNA signatures

Frontiers in Genetics

Volumn 4, Issue JUN, 2013, Pages

  Madhavan, Dharanija ^a,b   Cuk, Katarina ^a,b   Burwinkel, Barbara ^a,b   Yang, Rongxi ^a,b  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

Biomarkers; Cancer; circulating miRNA; Detection marker; Prognostic marker

Indexed keywords

EID: 84883525890     PISSN: None     EISSN: 16648021     Source Type: Journal    
DOI: 10.3389/fgene.2013.00116     Document Type: Review

References (72)

1. Baraniskin, A., Nopel-Dunnebacke, S., Ahrens, M., Jensen, S. G., Zollner, H., Maghnouj, A., et al. (2013). Circulating U2 small nuclear RNA fragments as a novel diagnostic biomarker for pancreatic and colorectal adenocarcinoma. Int. J. Cancer 132, e48-e57. doi: 10.1002/ijc.27791
2. Bianchi, F., Nicassio, F., Marzi, M., Belloni, E., Dall'olio, V., Bernard, L., et al. (2011). A serum circulating miRNA diagnostic test to identify asymptomatic high-risk individuals with early stage lung cancer. EMBO Mol. Med. 3, 495-503. doi: 10.1002/emmm.201100154
3. Boeri, M., Verri, C., Conte, D., Roz, L., Modena, P., Facchinetti, F., et al. (2011). MicroRNA signatures in tissues and plasma predict development and prognosis of computed tomography detected lung cancer. Proc. Natl. Acad. Sci. U.S.A. 108, 3713-3718. doi: 10.1073/pnas.1100048108
4. Brase, J. C., Johannes, M., Schlomm, T., Falth, M., Haese, A., Steuber, T., et al. (2011). Circulating miRNAs are correlated with tumor progression in prostate cancer. Int. J. Cancer 128, 608-616. doi: 10.1002/ijc.25376
5. Bryant, R. J., Pawlowski, T., Catto, J. W., Marsden, G., Vessella, R. L., Rhees, B., et al. (2012). Changes in circulating microRNA levels associated with prostate cancer. Br. J. Cancer 106, 768-774. doi: 10.1038/bjc.2011.595
6. Cai, H., Yuan, Y., Hao, Y. F., Guo, T. K., Wei, X., and Zhang, Y. M. (2013). Plasma microRNAs serve as novel potential biomarkers for early detection of gastric cancer. Med. Oncol. 30, 452. doi: 10.1007/s12032-012-0452-0
7. Chen, W., Cai, F., Zhang, B., Barekati, Z., and Zhong, X. Y. (2012a). The level of circulating miRNA-10b and miRNA-373 in detecting lymph node metastasis of breast cancer: potential biomarkers. Tumour Biol. 34, 455-462. doi: 10.1007/s13277-012-0570-5
8. Chen, Z. H., Zhang, G. L., Li, H. R., Luo, J. D., Li, Z. X., Chen, G. M., et al. (2012b). A panel of five circulating microRNAs as potential biomarkers for prostate cancer. Prostate 72, 1443-1452. doi: 10.1002/pros.22495
9. Chen, X., Ba, Y., Ma, L., Cai, X., Yin, Y., Wang, K., et al. (2008). Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res. 18, 997-1006. doi: 10.1038/cr.2008.282
10. Cheng, H., Zhang, L., Cogdell, D. E., Zheng, H., Schetter, A. J., Nykter, M., et al. (2011). Circulating plasma MiR-141 is a novel biomarker for metastatic colon cancer and predicts poor prognosis. PLoS ONE 6:e17745. doi: 10.1371/journal.pone.0017745
11. Chim, S. S., Shing, T. K., Hung, E. C., Leung, T. Y., Lau, T. K., Chiu, R. W., et al. (2008). Detection and characterization of placental microRNAs in maternal plasma. Clin. Chem. 54, 482-490. doi: 10.1373/clinchem.2007.097972
12. Cuk, K., Zucknick, M., Heil, J., Madhavan, D., Schott, S., Turchinovich, A., et al. (2013). Circulating microRNAs in plasma as early detection markers for breast cancer. Int. J. Cancer 32, 1602-1612. doi: 10.1002/ijc.27799
13. Fang, C., Zhu, D. X., Dong, H. J., Zhou, Z. J., Wang, Y. H., Liu, L., et al. (2012). Serum microRNAs are promising novel biomarkers for diffuse large B cell lymphoma. Ann. Hematol. 91, 553-559. doi: 10.1007/s00277-011-1350-9
14. Fayyad-Kazan, H., Bitar, N., Najar, M., Lewalle, P., Fayyad-Kazan, M., Badran, R., et al. (2013). Circulating miR-150 and miR-342 in plasma are novel potential biomarkers for acute myeloid leukemia. J. Transl. Med. 11, 31. doi: 10.1186/1479-5876-11-31
15. Ferlay, J., Shin, H. R., Bray, F., Forman, D., Mathers, C, and Parkin, D. M. (2008). Cancer Incidence and Mortality Worldwide. GLOBOCAN (2008). v2.0. IARC CancerBase No. 10 [Internet]. Available online at: http://globocan.iarc.fr/
16. Foss, K. M., Sima, C., Ugolini, D., Neri, M., Allen, K. E., and Weiss, G. J. (2011). miR-1254 and miR-574-5p: serum-based microRNA biomarkers for early-stage non-small cell lung cancer. J. Thorac. Oncol. 6, 482-488. doi: 10.1097/JTO.0b013e318208c785
17. Giraldez, M. D., Lozano, J. J., Ramirez, G., Hijona, E., Bujanda, L., Castells, A., et al. (2012). Circulating microRNAs as biomarkers of colorectal cancer: results from a genome-wide profiling and validation study. Clin. Gastroenterol. Hepatol. 11, 681-688. doi: 10.1016/j.cgh.2012.12.009
18. Gonzales, J. C., Fink, L. M., Goodman, O. B. Jr., Symanowski, J. T., Vogelzang, N. J., and Ward, D. C. (2011). Comparison of circulating MicroRNA 141 to circulating tumor cells, lactate dehydrogenase, and prostate-specific antigen for determining treatment response in patients with metastatic prostate cancer. Clin. Genitourin. Cancer 9, 39-45. doi: 10.1016/j.clgc.2011.05.008
19. Guo, H. Q., Huang, G. L., Guo, C. C., Pu, X. X., and Lin, T. Y. (2010). Diagnostic and prognostic value of circulating miR-221 for extranodal natural killer/T-cell lymphoma. Dis. Markers 29, 251-258. doi: 10.3233/DMA-2010-0755
20. Hanash, S. M., Baik, C. S., and Kallioniemi, O. (2011). Emerging molecular biomarkers-blood-based strategies to detect and monitor cancer. Nat. Rev. Clin. Oncol. 8, 142-150. doi: 10.1038/nrclinonc.2010.220
21. Harris, L., Fritsche, H., Mennel, R., Norton, L., Ravdin, P., Taube, S., et al. (2007). American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancer. J. Clin. Oncol. 25, 5287-5312. doi: 10.1200/JCO.2007.14.2364
22. Heegaard, N. H., Schetter, A. J., Welsh, J. A., Yoneda, M., Bowman, E. D., and Harris, C. C. (2012). Circulating micro-RNA expression profiles in early stage nonsmall cell lung cancer. Int. J. Cancer 130, 1378-1386. doi: 10.1002/ijc.26153
23. Hu, Z., Chen, X., Zhao, Y., Tian, T., Jin, G., Shu, Y., et al. (2010). Serum microRNA signatures identified in a genome-wide serum microRNA expression profiling predict survival of non-small-cell lung cancer. J. Clin. Oncol. 28, 1721-1726. doi: 10.1200/JCO.2009.24.9342
24. Huang, Z., Huang, D., Ni, S., Peng, Z., Sheng, W., and Du, X. (2010). Plasma microRNAs are promising novel biomarkers for early detection of colorectal cancer. Int. J. Cancer 127, 118-126. doi: 10.1002/ijc.25007
25. Kaduthanam, S., Gade, S., Meister, M., Brase, J. C., Johannes, M., Dienemann, H., et al. (2013). Serum miR-142-3p is associated with early relapse in operable lung adenocarcinoma patients. Lung Cancer 80, 223-227. doi: 10.1016/j.lungcan.2013.01.013
26. Kanaan, Z., Rai, S. N., Eichenberger, M. R., Roberts, H., Keskey, B., Pan, J., et al. (2012). Plasma miR-21: a potential diagnostic marker of colorectal cancer. Ann. Surg. 256, 544-551. doi: 10.1097/SLA.0b013e318265bd6f
27. Keller, A., Leidinger, P., Gislefoss, R., Haugen, A., Langseth, H., Staehler, P., et al. (2011). Stable serum miRNA profiles as potential tool for non-invasive lung cancer diagnosis. RNA Biol. 8, 506-516. doi: 10.4161/rna.8.3.14994
28. Konishi, H., Ichikawa, D., Komatsu, S., Shiozaki, A., Tsujiura, M., Takeshita, H., et al. (2012). Detection of gastric cancer-associated microRNAs on microRNA microarray comparing pre- and post-operative plasma. Br. J. Cancer 106, 740-747. doi: 10.1038/bjc.2011.588
29. Lawrie, C. H., Gal, S., Dunlop, H. M., Pushkaran, B., Liggins, A. P., Pulford, K., et al. (2008). Detection of elevated levels of tumour-associated microRNAs in serum of patients with diffuse large B-cell lymphoma. Br. J. Haematol. 141, 672-675. doi: 10.1111/j.1365-2141.2008.07077.x
30. Le, H. B., Zhu, W. Y., Chen, D. D., He, J. Y., Huang, Y. Y., Liu, X. G., et al. (2012). Evaluation of dynamic change of serum miR-21 and miR-24 in pre- and post-operative lung carcinoma patients. Med. Oncol. 29, 3190-3197. doi: 10.1007/s12032-012-0303-z
31. Li, B. S., Zhao, Y. L., Guo, G., Li, W., Zhu, E. D., Luo, X., et al. (2012a). Plasma microRNAs, miR-223, miR-21 and miR-218, as novel potential biomarkers for gastric cancer detection. PLoS ONE 7:e41629. doi: 10.1371/journal.pone.0041629
32. Li, C., Li, J. F., Cai, Q., Qiu, Q. Q., Yan, M., Liu, B. Y., et al. (2012b). MiRNA-199a-3p in Plasma as a potential diagnostic biomarker for gastric cancer. Ann. Surg. Oncol. doi: 10.1245/s10434-012-2600-3. [Epub ahead of print].
33. Liu, H., Zhu, L., Liu, B., Yang, L., Meng, X., Zhang, W., et al. (2012a). Genome-wide microRNA profiles identify miR-378 as a serum biomarker for early detection of gastric cancer. Cancer Lett. 316, 196-203. doi: 10.1016/j.canlet.2011.10.034
34. Liu, X. G., Zhu, W. Y., Huang, Y. Y., Ma, L. N., Zhou, S. Q., Wang, Y. K., et al. (2012b). High expression of serum miR-21 and tumor miR-200c associated with poor prognosis in patients with lung cancer. Med. Oncol. 29, 618-626. doi: 10.1007/s12032-011-9923-y
35. Liu, R., Zhang, C., Hu, Z., Li, G., Wang, C., Yang, C., et al. (2011). A five-microRNA signature identified from genome-wide serum microRNA expression profiling serves as a fingerprint for gastric cancer diagnosis. Eur. J. Cancer 47, 784-791. doi: 10.1016/j.ejca.2010.10.025
36. Lumachi, F., Brandes, A. A., Ermani, M., Bruno, G., and Boccagni, P. (2000). Sensitivity of serum tumor markers CEA and CA 15-3 in breast cancer recurrences and correlation with different prognostic factors. Anticancer Res. 20, 4751-4755.
37. Madhavan, D., Zucknick, M., Wallwiener, M., Cuk, K., Modugno, C., Scharpff, M., et al. (2012). Circulating miRNAs as surrogate markers for circulating tumor cells and prognostic markers in metastatic breast cancer. Clin. Cancer Res. 18, 5972-5982. doi: 10.1158/1078-0432.CCR-12-1407
38. Mahn, R., Heukamp, L. C., Rogenhofer, S., von Ruecker, A., Muller, S. C., and Ellinger, J. (2011). Circulating microRNAs (miRNA) in serum of patients with prostate cancer. Urology 77, 1265.e9-1265.e16. doi: 10.1016/j.urology.2011.01.020
39. Mar-Aguilar, F., Mendoza-Ramirez, J. A., Malagon-Santiago, I., Espino-Silva, P. K., Santuario-Facio, S. K., Ruiz-Flores, P., et al. (2013). Serum circulating microRNA profiling for identification of potential breast cancer biomarkers. Dis. Markers 34, 163-169. doi: 10.3233/DMA-120957
40. Mitchell, P. S., Parkin, R. K., Kroh, E. M., Fritz, B. R., Wyman, S. K., Pogosova-Agadjanyan, E. L., et al. (2008). Circulating microRNAs as stable blood-based markers for cancer detection. Proc. Natl. Acad. Sci. U.S.A. 105, 10513-10518. doi: 10.1073/pnas.0804549105
41. Ng, E. K., Chong, W. W., Jin, H., Lam, E. K., Shin, V. Y., Yu, J., et al. (2009). Differential expression of microRNAs in plasma of patients with colorectal cancer: a potential marker for colorectal cancer screening. Gut 58, 1375-1381. doi: 10.1136/gut.2008.167817
42. Ng, E. K., Li, R., Shin, V. Y., Jin, H. C., Leung, C. P., Ma, E. S., et al. (2013). Circulating microRNAs as specific biomarkers for breast cancer detection. PLoS ONE 8:e53141. doi: 10.1371/journal.pone.0053141
43. Nguyen, H. C., Xie, W., Yang, M., Hsieh, C. L., Drouin, S., Lee, G. S., et al. (2012). Expression differences of circulating microRNAs in metastatic castration resistant prostate cancer and low-risk, localized prostate cancer. Prostate 73, 346-354. doi: 10.1002/pros.22572
44. Ohyashiki, K., Umezu, T., Yoshizawa, S., Ito, Y., Ohyashiki, M., Kawashima, H., et al. (2011). Clinical impact of down-regulated plasma miR-92a levels in non-Hodgkin's lymphoma. PLoS ONE 6:e16408. doi: 10.1371/journal.pone.0016408
45. Pfütze, K., Lou, X., and Burwinkel, B. (2013). MicroRNA Signatures as Biomarkers of Colorectal Cancer. New Jersey, NJ: Blackwell Publisher.
46. Pu, X. X., Huang, G. L., Guo, H. Q., Guo, C. C., Li, H., Ye, S., et al. (2010). Circulating miR-221 directly amplified from plasma is a potential diagnostic and prognostic marker of colorectal cancer and is correlated with p53 expression. J. Gastroenterol. Hepatol. 25, 1674-1680. doi: 10.1111/j.1440-1746.2010.06417.x
47. Roth, C., Rack, B., Muller, V., Janni, W., Pantel, K., and Schwarzenbach, H. (2010). Circulating microRNAs as blood-based markers for patients with primary and metastatic breast cancer. Breast Cancer Res. 12, R90. doi: 10.1186/bcr2766
48. Shen, J., Hruby, G. W., McKiernan, J. M., Gurvich, I., Lipsky, M. J., Benson, M. C., et al. (2012). Dysregulation of circulating microRNAs and prediction of aggressive prostate cancer. Prostate 72, 1469-1477. doi: 10.1002/pros.22499
49. Shen, J., Todd, N. W., Zhang, H., Yu, L., Lingxiao, X., Mei, Y., et al. (2011). Plasma microRNAs as potential biomarkers for non-small-cell lung cancer. Lab. Invest. 91, 579-587. doi: 10.1038/labinvest.2010.194
50. Si, H., Sun, X., Chen, Y., Cao, Y., Chen, S., Wang, H., et al. (2013). Circulating microRNA-92a and microRNA-21 as novel minimally invasive biomarkers for primary breast cancer. J. Cancer Res. Clin. Oncol. 139, 223-229. doi: 10.1007/s00432-012-1315-y
51. Siegel, R., Naishadham, D., and Jemal, A. (2012). Cancer statistics, 2012. CA Cancer J. Clin. 62, 10-29. doi: 10.3322/caac.20138
52. Song, M. Y., Pan, K. F., Su, H. J., Zhang, L., Ma, J. L., Li, J. Y., et al. (2012). Identification of serum microRNAs as novel non-invasive biomarkers for early detection of gastric cancer. PLoS ONE. 7:e33608. doi: 10.1371/journal.pone.0033608
53. Sun, Y., Wang, M., Lin, G., Sun, S., Li, X., Qi, J., et al. (2012). Serum microRNA-155 as a potential biomarker to track disease in breast cancer. PLoS ONE 7:e47003. doi: 10.1371/journal.pone.0047003
54. Tanaka, M., Oikawa, K., Takanashi, M., Kudo, M., Ohyashiki, J., Ohyashiki, K., et al. (2009). Down-regulation of miR-92 in human plasma is a novel marker for acute leukemia patients. PLoS ONE 4:e5532. doi: 10.1371/journal.pone.0005532
55. Tang, D., Shen, Y., Wang, M., Yang, R., Wang, Z., Sui, A., et al. (2013). Identification of plasma microRNAs as novel noninvasive biomarkers for early detection of lung cancer. Eur. J. Cancer Prev. doi: 10.1097/CEJ.0b013e32835f3be9. [Epub ahead of print].
56. Tsujiura, M., Ichikawa, D., Komatsu, S., Shiozaki, A., Takeshita, H., Kosuga, T., et al. (2010). Circulating microRNAs in plasma of patients with gastric cancers. Br. J. Cancer 102, 1174-1179. doi: 10.1038/sj.bjc.6605608
57. Turchinovich, A., and Burwinkel, B. (2012). Distinct AGO1 and AGO2 associated miRNA profiles in human cells and blood plasma. RNA Biol. 9, 1066-1075. doi: 10.4161/rna.21083
58. Turchinovich, A., Weiz, L., and Burwinkel, B. (2012). Extracellular miRNAs: the mystery of their origin and function. Trends Biochem. Sci. 37, 460-465. doi: 10.1016/j.tibs.2012.08.003
59. Turchinovich, A., Weiz, L., Langheinz, A., and Burwinkel, B. (2011). Characterization of extracellular circulating microRNA. Nucleic Acids Res. 39, 7223-7233. doi: 10.1093/nar/gkr254
60. Uehara, M., Kinoshita, T., Hojo, T., Akashi-Tanaka, S., Iwamoto, E., and Fukutomi, T. (2008). Long-term prognostic study of carcinoembryonic antigen (CEA) and carbohydrate antigen 15-3 (CA 15-3) in breast cancer. Int. J. Clin. Oncol. 13, 447-451. doi: 10.1007/s10147-008-0773-3
61. van Schooneveld, E., Wouters, M. C., Van der Auwera, I., Peeters, D. J., Wildiers, H., Van Dam, P. A., et al. (2012). Expression profiling of cancerous and normal breast tissues identifies microRNAs that are differentially expressed in serum from patients with (metastatic) breast cancer and healthy volunteers. Breast Cancer Res. 14, R34. doi: 10.1186/bcr3127
62. Wang, H., Tan, G., Dong, L., Cheng, L., Li, K., Wang, Z., et al. (2012a). Circulating MiR-125b as a marker predicting chemoresistance in breast cancer. PLoS ONE 7:e34210. doi: 10.1371/journal.pone.0034210
63. Wang, M., Gu, H., Wang, S., Qian, H., Zhu, W., Zhang, L., et al. (2012b). Circulating miR-17-5p and miR-20a: molecular markers for gastric cancer. Mol. Med. Rep. 5, 1514-1520. doi: 10.3892/mmr.2012.828
64. Wang, Q., Huang, Z., Ni, S., Xiao, X., Xu, Q., Wang, L., et al. (2012c). Plasma miR-601 and miR-760 are novel biomarkers for the early detection of colorectal cancer. PLoS ONE 7:e44398. doi: 10.1371/journal.pone.0044398
65. Wang, L. G., and Gu, J. (2012). Serum microRNA-29a is a promising novel marker for early detection of colorectal liver metastasis. Cancer Epidemiol. 36, e61-e67. doi: 10.1016/j.canep.2011.05.002
66. Wei, J., Gao, W., Zhu, C. J., Liu, Y. Q., Mei, Z., Cheng, T., et al. (2011). Identification of plasma microRNA-21 as a biomarker for early detection and chemosensitivity of non-small cell lung cancer. Chin. J. Cancer 30, 407-414. doi: 10.5732/cjc.010.10522
67. Zeng, R. C., Zhang, W., Yan, X. Q., Ye, Z. Q., Chen, E. D., Huang, D. P., et al. (2013). Down-regulation of miRNA-30a in human plasma is a novel marker for breast cancer. Med. Oncol. 30, 477. doi: 10.1007/s12032-013-0477-z
68. Zhang, H. L., Yang, L. F., Zhu, Y., Yao, X. D., Zhang, S. L., Dai, B., et al. (2011). Serum miRNA-21: elevated levels in patients with metastatic hormone-refractory prostate cancer and potential predictive factor for the efficacy of docetaxel-based chemotherapy. Prostate 71, 326-331. doi: 10.1002/pros.21246
69. Zhao, H., Shen, J., Medico, L., Wang, D., Ambrosone, C. B., and Liu, S. (2010). A pilot study of circulating miRNAs as potential biomarkers of early stage breast cancer. PLoS ONE 5:e13735. doi: 10.1371/journal.pone.0013735
70. Zheng, D., Haddadin, S., Wang, Y., Gu, L. Q., Perry, M. C., Freter, C. E., et al. (2011). Plasma microRNAs as novel biomarkers for early detection of lung cancer. Int. J. Clin. Exp. Pathol. 4, 575-586.
71. Zhi, F., Cao, X., Xie, X., Wang, B., Dong, W., Gu, W., et al. (2013). Identification of circulating micrornas as potential biomarkers for detecting acute myeloid leukemia. PLoS ONE 8:e56718. doi: 10.1371/journal.pone.0056718
72. Zhu, W., Qin, W., Atasoy, U., and Sauter, E. R. (2009). Circulating microRNAs in breast cancer and healthy subjects. BMC Res. Notes 2:89. doi: 10.1186/1756-0500-2-89